MedTrace Logo

MAKv1 Exoskeleton for TKA Patients: a Safety, Usability and Clinical Effects Trial of an Early Intervention

NCT05544409 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2022-09-16

No results posted yet for this study

Summary

The present study analyzes the effects of using a portable single limb exoskeleton (MAKv1) in patients with total knee artrhoplasty (TKA). Safety, usability and clinical effects of an early intervention program with the device with an early implementation are studied.

Conditions

  • Total Knee Arthroplasty

Interventions

DEVICE

MAKv1

1 hour sessions with the MAKv1 exoskeleton, thrice per week during 1 month

Sponsors & Collaborators

  • MarsiBionics

    lead INDUSTRY

Principal Investigators

  • Ana Luisa López Morón · Hospital Universitario Sanitas La Zarzuela

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-12
Primary Completion
2021-02-08
Completion
2021-02-08

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05544409 on ClinicalTrials.gov